+91-22-45045900 sales@clearsynth.com
Stable Isotopes Product Detail
Home Stable Isotopes CS-T-98818

Linsitinib-d3

Explore technical data, documentation access, molecular information and enquiry options for this Clearsynth research product.

Product Code: CS-T-98818 Stable Isotopes Research Use Only
Linsitinib-d3
Category
Stable Isotopes
API Family
--
Product Code
CS-T-98818
Research Status
For Laboratory Use

Linsitinib-d3

Stable Isotopes
Stock Status: : Enquire Live

CAT No.
CS-T-98818
CAS No.
--
Molecular Formula
C26H20D3N5O
Molecular Weight
424.51
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal or Veterinary use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
-
Product Code
CS-T-98818
M.F.
C26H20D3N5O
M.W.
424.51
Category
Stable Isotopes
Storage Condition
Refer MSDS for complete information.
IUPAC Name
Linsitinib-d3
References
"Mulvihill, M.M.J. et al.: Fut. Med. Chem., 1, 1153 (2009); Flanigan, S.A. et al.: Clin. Cancer Res., 16, 5436 (2010); McKinley, E.T. et al.: Clin. Cancer Res., 17, 3332 (2011);"
Synonyms
"cis-3-[8-Amino-1-(2-phenyl-7-quinolinyl)imidazo[1,5-a]pyrazin-3-yl]-1-(methyl-d3)cyclobutanol; OSI 906-d3; OSI 906AA-d3;"
Application Notes
"Labelled Linsitinib (L469020). Linsitinib is a small-molecule dual insulin-like growth factor-1 receptor (IGF-IR) and insulin receptor (IR) kinase inhibitor. IGF-I receptor (IGF-IR) has been implicated in the promotion of tumorigenesis, metastasis and resistance to cancer therapies and thus Linsitinib may be a useful anticancer agent."
Hazard Compound
Refer MSDS for complete information.
Overview
"Labelled Linsitinib (L469020). Linsitinib is a small-molecule dual insulin-like growth factor-1 receptor (IGF-IR) and insulin receptor (IR) kinase inhibitor. IGF-I receptor (IGF-IR) has been implicated in the promotion of tumorigenesis, metastasis and resistance to cancer therapies and thus Linsitinib may be a useful anticancer agent."

Customers Also Viewed

Bedaquiline-d6

Bedaquiline-d6

CAT No: CS-O-06435
CAS No: 843663-66-1(Unlabeled)
N-Butyl Nortadalafil-d9

N-Butyl Nortadalafil-d9

CAT No: CS-T-97727
 Sodium Curcumin β-D-Glucuronide-d3

Sodium Curcumin β-D-Glucuronide-d3

CAT No: CS-T-94851
CAS No: 227466-72-0 (unlabled)
Benzene, 1,​4-​dimethoxy-​2-​(methyl-​d3)

Benzene, 1,​4-​dimethoxy-​2-​(methyl-​d3)

CAT No: CS-O-42842
CAS No: 61552-24-7
E-Rilpivirine-d4

E-Rilpivirine-d4

CAT No: CS-B-00371
CAS No: 500287-94-5 (unlabelled)
Flunarizine Epoxide-D₈

Flunarizine Epoxide-D₈

CAT No: CS-T-103944
CAS No: 144917-53-3(unlabelled)
m-Hydroxyhippuric Acid-13C2, 15N

m-Hydroxyhippuric Acid-13C2, 15N

CAT No: CS-T-100205
 Mirtazapine-d3

Mirtazapine-d3

CAT No: CS-O-06784
CAS No: 1216678-68-0
N-Dehydroxyzileuton-D4 (major)

N-Dehydroxyzileuton-D4 (major)

CAT No: CS-T-100550
 Hexanoyl-L-carnitine-(N-methyl-d3) Chloride

Hexanoyl-L-carnitine-(N-methyl-d3) Chloride

CAT No: CS-T-103047
CAS No: NA

Refund Policy

We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of material handover. We have invested in the highest quality packaging materials and use international logistics partners to service our customers. If there is an issue with one or more of our products, it must be reported to us within 45 days of your receiving shipment for refund or account credit eligibility.

Downloading MSDS…
Quick Enquiry Email Us
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.